13F reference period
Q2 2026
Security Snapshot
ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.000001 per share (ACTU) Institutional Ownership
CUSIP: 005083100
13F Institutional Holders and Ownership History from Q3 2024 to Q3 2026
Institutions Reporting
62
Shares (Excl. Options)
13.44M
Full value: 13,440,233 · shares · 30 Jun 2026Price
$1.53
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.000001 per share
- Symbol
- ACTU on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 13,440,233
- Total 13F value
- $20,563,425
- Portfolio coverage rank
- 0%
- Share change
- -493,603
- Value change
- -$1,114,361
- Number of holders
- 62
- Shares outstanding
- 54,874,701
- SEC-reported price per share
- $0.47
- Insider filing price
- $0.47
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- ACTU - ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.000001 per share is tracked under CUSIP 005083100.
- 62 institutions reported positions in Q2 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 61 to 62 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$37.97M
Full value: $37,968,649 · USD · 31 Mar 2026.$20.56M
Full value: $20,563,425 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 62 institutions filings for Q2 2026.
Security key
005083100
13F reference period
Q2 2026
13F holders
62
13D/G owners
3
CIK / CUSIP context first
Open Q2 2026 holders
ACTU full holder history
ACTUATE THERAPEUTICS, INC. SEC filings
ACTUATE THERAPEUTICS, INC. company facts
ACTUATE THERAPEUTICS, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 005083100:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
ACTU
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BIOS Fund I, LP | 50% | -2.9% | $112,734,207 | +$1,733,259 | 10,267,232 | +1.6% | AARON G.L. FLETCHER | 27 Jun 2025 |
| Hexstone Capital LLC | 7.7% | $3,294,084 | 4,225,352 | Hexstone Capital LLC | 27 Oct 2026 | |||
| Voss Capital, LP | 7.7% | +48% | $5,013,716 | +$1,620,812 | 1,814,263 | +48% | Voss Capital, LP | 31 Mar 2026 |
As of 30 Jun 2026,
62
institutional investors reported holding
shares of
ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.000001 per share (ACTU).
This represents
24%
of the company’s total
outstanding shares.
13.44M
Full value: 13,440,233 · shares · 30 Jun 202654.87M
Full value: 54,874,701 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
24%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BIOS Capital Management, LP | 18% | 10,049,996 | 0% | 37% | $15,376,494 |
| Voss Capital, LP | 3.1% | 1,725,000 | 0% | 0.13% | $2,639,250 |
| VANGUARD CAPITAL MANAGEMENT LLC | 0.72% | 393,433 | -1.8% | 0% | $601,952 |
| AQR CAPITAL MANAGEMENT LLC | 0.23% | 127,493 | +370% | 0% | $195,064 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.21% | 112,554 | -51% | 0% | $172,207 |
| Texas Capital Bank Wealth Management Services Inc | 0.19% | 102,612 | +8.5% | 0.01% | $156,997 |
| Palogic Value Management, L.P. | 0.18% | 100,000 | 0% | 0.05% | $153,000 |
| MILLENNIUM MANAGEMENT LLC | 0.18% | 96,684 | 0% | $147,927 | |
| BlackRock, Inc. | 0.16% | 90,035 | -79% | 0% | $137,754 |
| ABS Investment Management LLC | 0.13% | 73,186 | 0% | 0.12% | $111,975 |
| VANGUARD FIDUCIARY TRUST CO | 0.1% | 54,497 | -13% | 0% | $83,380 |
| Rock Creek Group LLC | 0.07% | 39,263 | 0% | 0.01% | $60,072 |
| JANE STREET GROUP, LLC | 0.07% | 39,132 | 0% | $59,872 | |
| HighTower Advisors, LLC | 0.07% | 36,461 | 0% | $55,785 | |
| GOLDMAN SACHS GROUP INC | 0.06% | 35,498 | +186% | 0% | $54,312 |
| SFMG, LLC | 0.06% | 33,000 | 0% | 0% | $50,490 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.05% | 28,182 | 0% | $43,118 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.04% | 23,482 | -24% | 0% | $35,927 |
| STATE STREET CORP | 0.04% | 21,850 | -67% | 0% | $33,431 |
| NORTHERN TRUST CORP | 0.04% | 21,220 | -78% | 0% | $32,467 |
| Mariner, LLC | 0.04% | 21,082 | 0% | $32,257 | |
| Gleason Group, Inc. | 0.03% | 19,028 | 0% | 0% | $29,113 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 0.03% | 18,518 | -41% | 0% | $28,333 |
| Qube Research & Technologies Ltd | 0.03% | 15,256 | 0% | $23,342 | |
| Virtu Financial LLC | 0.03% | 14,611 | 0% | $22,000 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
9
Headline period
Q2 2026
Rows shown
1-9 of 9
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 48,307 | $37,208 | -$36,221 | $0.78 | 5 |
| 2026 Q2 | 13,440,233 | $20,563,425 | -$1,114,361 | $1.53 | 62 |
| 2026 Q1 | 13,857,769 | $37,968,649 | +$1,985,654 | $2.74 | 61 |
| 2025 Q4 | 13,110,237 | $80,234,480 | +$6,660,093 | $6.12 | 44 |
| 2025 Q3 | 12,026,097 | $80,455,749 | +$5,410,880 | $6.69 | 42 |
| 2025 Q2 | 11,217,203 | $68,541,901 | +$4,868,272 | $6.11 | 38 |
| 2025 Q1 | 10,401,592 | $70,445,498 | +$1,934,199 | $6.77 | 25 |
| 2024 Q4 | 10,116,136 | $80,524,037 | -$1,087,916 | $7.96 | 19 |
| 2024 Q3 | 382,167 | $2,847,155 | +$2,847,155 | $7.45 | 10 |